Facebook Linkedin RSS Twitter Youtube
Home 2023

Neuropathic pain

Drug Candidate’s ‘Inside Job’ Obstructs Pain Channel, Avoids Side Effects
Drug Discovery

Drug Candidate’s ‘Inside Job’ Obstructs Pain Channel, Avoids Side Effects

Antibody Found Effective against Autoimmune NMO in Preclinical Study
Drug Discovery

Antibody Found Effective against Autoimmune NMO in Preclinical Study

Optogenetic Study Identifies Therapeutic Target for Inflammatory Diseases and Neuropathic Pain
Drug Discovery

Optogenetic Study Identifies Therapeutic Target for Inflammatory Diseases and Neuropathic Pain

Neuropathic Pain Eased by Novel Light-Based Technique
Drug Discovery

Neuropathic Pain Eased by Novel Light-Based Technique

New Diagnostic Biomarkers and Method Uncovered for MS
News

New Diagnostic Biomarkers and Method Uncovered for MS

Lexicon Wins FDA Nod for First Oral Carcinoid Syndrome Diarrhea Drug
Industry News

Lexicon Wins FDA Nod for First Oral Carcinoid Syndrome Diarrhea Drug

Lexicon Acquires Rights to Pain Candidate Developed with BMS
Industry News

Lexicon Acquires Rights to Pain Candidate Developed with BMS

Astellas, Chromocell Launch Up-to-$515M+ Pain Drugs Collaboration
Drug Discovery

Astellas, Chromocell Launch Up-to-$515M+ Pain Drugs Collaboration

Up to $12M Deal Expands Acorda Offerings to Neuropathic Pain
Drug Discovery

Up to $12M Deal Expands Acorda Offerings to Neuropathic Pain

FDA Clears Pfizer’s Lyrica for Spinal Cord Injury Neuropathic Pain
Drug Discovery

FDA Clears Pfizer’s Lyrica for Spinal Cord Injury Neuropathic Pain

123...6Page 1 of 6
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.